Avita Medical Stock Analysis

RCEL Stock  USD 3.47  0.02  0.58%   
Avita Medical holds a debt-to-equity ratio of 0.012. At this time, Avita Medical's Interest Debt Per Share is quite stable compared to the past year. Debt To Assets is expected to rise to 0.55 this year, although the value of Net Debt To EBITDA is projected to rise to (0.49). Avita Medical's financial risk is the risk to Avita Medical stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Avita Medical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Avita Medical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Avita Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Avita Medical's stakeholders.
For most companies, including Avita Medical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Avita Medical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Avita Medical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
11.7695
Book Value
(0.22)
Operating Margin
(0.54)
Profit Margin
(0.67)
Return On Assets
(0.36)
At this time, Avita Medical's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 96.3 M this year, although the value of Change To Liabilities will most likely fall to about 23.9 K.
Avita Medical is undervalued with Real Value of 4.62 and Target Price of 8.15. The main objective of Avita Medical stock analysis is to determine its intrinsic value, which is an estimate of what Avita Medical is worth, separate from its market price. There are two main types of Avita Medical's stock analysis: fundamental analysis and technical analysis.
The Avita Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.

Avita Stock Analysis Notes

About 17.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.81. Avita Medical had not issued any dividends in recent years. The entity had 1:5 split on the 30th of June 2020. AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California. Avita Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 116 people. To find out more about Avita Medical contact James Corbett at 661 367 9170 or learn more at https://avitamedical.com.

Avita Medical Quarterly Total Revenue

17.06 Million

Avita Medical Investment Alerts

Avita Medical generated a negative expected return over the last 90 days
Avita Medical has high historical volatility and very poor performance
Avita Medical has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 64.25 M. Net Loss for the year was (61.84 M) with profit before overhead, payroll, taxes, and interest of 60.63 M.
Avita Medical currently holds about 84.17 M in cash with (48.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.67.
Avita Medical has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Brokerages Set Avita Medical Inc. Price Target at 10.50

Avita Medical Upcoming and Recent Events

22nd of February 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
22nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Avita Largest EPS Surprises

Earnings surprises can significantly impact Avita Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-02-18
2019-12-31-0.03-0.0662-0.0362120 
2021-05-14
2021-03-31-0.3-0.260.0413 
2023-02-23
2022-12-31-0.29-0.220.0724 
View All Earnings Estimates

Avita Medical Environmental, Social, and Governance (ESG) Scores

Avita Medical's ESG score is a quantitative measure that evaluates Avita Medical's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Avita Medical's operations that may have significant financial implications and affect Avita Medical's stock price as well as guide investors towards more socially responsible investments.

Avita Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Goldman Sachs Group Inc2025-06-30
93.7 K
Jane Street Group Llc2025-06-30
86.7 K
Charles Schwab Investment Management Inc2025-06-30
85.8 K
Marshall Wace Asset Management Ltd2025-06-30
76.8 K
Bank Of America Corp2025-06-30
62.6 K
D. E. Shaw & Co Lp2025-06-30
62 K
Nuveen, Llc2025-06-30
59.3 K
Citadel Advisors Llc2025-06-30
58.8 K
Bank Of New York Mellon Corp2025-06-30
55.3 K
Blackrock Inc2025-06-30
1.9 M
Vanguard Group Inc2025-06-30
1.5 M
Note, although Avita Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Avita Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 105.81 M.

Avita Profitablity

The company has Profit Margin (PM) of (0.67) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.54) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.54.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.96)(1.01)
Return On Capital Employed(1.09)(1.15)
Return On Assets(0.89)(0.94)
Return On Equity(15.81)(15.02)

Management Efficiency

Avita Medical has return on total asset (ROA) of (0.3633) % which means that it has lost $0.3633 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.4627) %, meaning that it created substantial loss on money invested by shareholders. Avita Medical's management efficiency ratios could be used to measure how well Avita Medical manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -1.01. The value of Return On Capital Employed is expected to slide to -1.15. At this time, Avita Medical's Intangible Assets are quite stable compared to the past year. Net Current Asset Value is expected to rise to about 2.9 M this year, although the value of Net Tangible Assets will most likely fall to about 51.6 M.
Last ReportedProjected for Next Year
Book Value Per Share 0.20  0.19 
Net Current Asset Value2.2 M2.9 M
Tangible Asset Value2.4 M4.1 M
Tangible Book Value Per Share(0.05)(0.05)
Enterprise Value Over EBITDA(7.55)(7.93)
Price Book Value Ratio 66.28  69.59 
Enterprise Value Multiple(7.55)(7.93)
Price Fair Value 66.28  69.59 
Enterprise Value326.9 M343.3 M
Avita Medical benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Operating Margin
(0.54)
Profit Margin
(0.67)
Beta
1.656
Return On Assets
(0.36)
Return On Equity
(17.46)

Technical Drivers

As of the 4th of January, Avita Medical shows the Mean Deviation of 2.49, risk adjusted performance of (0.07), and Standard Deviation of 4.26. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Avita Medical, as well as the relationship between them. Please confirm Avita Medical variance and value at risk to decide if Avita Medical is priced correctly, providing market reflects its regular price of 3.47 per share. Given that Avita Medical has information ratio of (0.13), we suggest you to validate Avita Medical's prevailing market performance to make sure the company can sustain itself at a future point.

Avita Medical Price Movement Analysis

Study
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Avita Medical price series.

Avita Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avita Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avita Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avita Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Avita Medical Outstanding Bonds

Avita Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Avita Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Avita bonds can be classified according to their maturity, which is the date when Avita Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Avita Medical Predictive Daily Indicators

Avita Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Avita Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Avita Medical Forecast Models

Avita Medical's time-series forecasting models are one of many Avita Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avita Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Avita Medical Bond Ratings

Avita Medical financial ratings play a critical role in determining how much Avita Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Avita Medical's borrowing costs.
Piotroski F Score
3
FrailView
Beneish M Score
(2.77)
Unlikely ManipulatorView

Avita Medical Debt to Cash Allocation

Many companies such as Avita Medical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Avita Medical currently holds 45.98 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Avita Medical has a current ratio of 9.45, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Avita Medical's use of debt, we should always consider it together with its cash and equity.

Avita Medical Total Assets Over Time

Avita Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Avita Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Avita Medical Debt Ratio

    
  55.0   
It seems about 44% of Avita Medical's assets are financed be debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Avita Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Avita Medical, which in turn will lower the firm's financial flexibility.

Avita Medical Corporate Bonds Issued

Avita Net Debt

Net Debt

30.18 Million

At this time, Avita Medical's Net Debt is quite stable compared to the past year.

About Avita Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avita Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avita shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avita Medical. By using and applying Avita Stock analysis, traders can create a robust methodology for identifying Avita entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.87)(0.91)
Operating Profit Margin(0.79)(0.83)
Net Loss(0.87)(0.91)
Gross Profit Margin 0.77  0.81 

Current Avita Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Avita analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Avita analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
8.15Strong Buy4Odds
Avita Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Avita analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Avita stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Avita Medical, talking to its executives and customers, or listening to Avita conference calls.
Avita Analyst Advice Details

Avita Stock Analysis Indicators

Avita Medical stock analysis indicators help investors evaluate how Avita Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Avita Medical shares will generate the highest return on investment. By understating and applying Avita Medical stock analysis, traders can identify Avita Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow22.1 M
Long Term Debt42.2 M
Common Stock Shares Outstanding25.9 M
Total Stockholder Equity4.5 M
Total Cashflows From Investing Activities37.4 M
Tax Provision54 K
Property Plant And Equipment Net13.6 M
Cash And Short Term Investments35.9 M
Cash14.1 M
Accounts Payable6.3 M
Net Debt31.9 M
50 Day M A3.6416
Total Current Liabilities20.2 M
Other Operating Expenses120.8 M
Non Current Assets Total22.7 M
Forward Price Earnings4.8193
Non Currrent Assets Other3.6 M
Stock Based Compensation13.5 M
When determining whether Avita Medical is a strong investment it is important to analyze Avita Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avita Medical's future performance. For an informed investment choice regarding Avita Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.81)
Revenue Per Share
2.702
Quarterly Revenue Growth
(0.13)
Return On Assets
(0.36)
Return On Equity
(17.46)
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.